Einav Sapir
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Health top 10%
- Vaccine Coverage and Hesitancy
Papers in
-
- COVID-19 epidemiological studies 1
- Co-authors
- Yaniv LustigGili Regev‐YochayElla MendelsonMichal MandelboimAmit HuppertVictoria IndenbaumLiraz OlmerCarmit Cohen
- Journals
- Eurosurveillance (1 paper)IEEE Transactions on Plasma Science (1 paper)Annals of Oncology (1 paper)The Laryngoscope (1 paper)The Lancet Respiratory Medicine (1 paper)
- Partner nations
- Israel
In The Last Decade
Einav Sapir
7 papers receiving 385 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Infectious Diseases 341
- Health 77
- Modeling and Simulation 40
- Animal Science and Zoology 42
- Obstetrics and Gynecology 18
Countries citing papers authored by Einav Sapir
This map shows the geographic impact of Einav Sapir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Einav Sapir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Einav Sapir more than expected).
Fields of papers citing papers by Einav Sapir
This network shows the impact of papers produced by Einav Sapir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Einav Sapir. The network helps show where Einav Sapir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Einav Sapir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers Hit paper breakdown → | 2021 | 232 |
| 3 | 2021 | 24 | |
| 4 | 2021 | 97 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 4 | |
| 7 | 1987 | 14 |
About Einav Sapir
Einav Sapir is a scholar working on Internal Medicine, Modeling and Simulation, Infectious Diseases, Health and Animal Science and Zoology, having authored 7 papers that have together received 389 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Bacillus and Francisella bacterial research (1 paper), Vascular Anomalies and Treatments (1 paper), COVID-19 epidemiological studies (1 paper), Economic and Financial Impacts of Cancer (1 paper), Heparin-Induced Thrombocytopenia and Thrombosis (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and Atrial Fibrillation Management and Outcomes (1 paper). The work is most often cited by research in Infectious Diseases (341 citations), Health (77 citations), Modeling and Simulation (40 citations), Animal Science and Zoology (42 citations) and Obstetrics and Gynecology (18 citations). Einav Sapir has collaborated with scholars based in Israel. Frequent co-authors include Yaniv Lustig, Gili Regev‐Yochay, Ella Mendelson, Michal Mandelboim, Amit Huppert, Victoria Indenbaum, Liraz Olmer, Carmit Cohen, Arnona Ziv and Carmit Rubin. Their work appears in journals such as Eurosurveillance, IEEE Transactions on Plasma Science, Annals of Oncology, The Laryngoscope and The Lancet Respiratory Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.